# TenX Biopharma, Inc. — Form D

TenX Biopharma, Inc. of PHILADELPHIA, PA, a company, filed a Form D exempt-offering notice with the SEC on 2010-03-02. The offering totals $6.0M, of which $5.5M was reported sold. Industry: Pharmaceuticals.

## Offering

- Filed: 2010-03-02
- Form: D
- Accession: 0001485860-10-000001
- Industry: Pharmaceuticals
- Exemptions: 06
- Total offering: $6.0M
- Amount sold: $5.5M
- Remaining: $475K
- Minimum investment: $10K
- Investors: 17
- Date of first sale: 2010-02-03
- Revenue range: $1 - $1,000,000
- SEC file number: 021-139163

## Issuer

- Name: TenX Biopharma, Inc.
- CIK: 0001485860
- Entity type: Corporation
- Jurisdiction: DELAWARE
- Incorporated: 2009
- Address: 109 NORTH ORIANNA STREET, PHILADELPHIA, PA, 19106
- Phone: (304) 982-1240

## Officers, directors & promoters (6)

| Name | Role | Location |
| --- | --- | --- |
| Nathan Chia Asher | Director | Bet Shemesh, L3 |
| GARDINER SMITH | Director | CARMEL, IN |
| Nathan Chia Asher | Executive Officer | Bet Shemesh, L3 |
| Robert Chia Harow | Executive Officer | Bet Shemesh, L3 |
| GARDINER SMITH | Executive Officer | CARMEL, IN |
| Chia Chia Sun | Executive Officer | Toronto, A6 |

## More

- [CIK 1485860 on SEC EDGAR (source of record)](https://www.sec.gov/cgi-bin/browse-edgar?action=getcompany&CIK=1485860&type=&dateb=&owner=include&count=40)
- [This page as markdown (for LLM agents)](https://search.stillhousedata.com/formd/0001485860-10-000001.md)
- [Search all SEC filings, advisers and people on Adviser Search](https://search.stillhousedata.com/)

---

Source: public SEC filing data via Adviser Search (https://search.stillhousedata.com).
Agents: this data is also queryable via MCP tools and read-only SQL — see https://search.stillhousedata.com/llms.txt.